title: Exclusive association of paraoxonase 1 with high-density lipoprotein particles in apolipoprotein A-I deficiency.
abstract: Paraoxonase1 (PON1) is a high-density lipoprotein (HDL)-associated protein which removes peroxidized lipids from lipoproteins. It has been proposed that apolipoprotein A-I (apoA-I) is an important determinant for its stabilization on HDL. However, little is known about its existence and activity in an apoA-I-deficient state in humans. To characterize the nature of PON1 in apoA-I deficiency, we investigated PON1 in an apoA-I-deficient patient. When serum was analyzed on fast protein liquid chromatography, PON1 protein was distributed almost exclusively on HDL despite the absence of apoA-I; on the other hand, 38.5% of PON1 protein was found in the lipoprotein-free fraction when the lipoproteins were fractionated through ultracentrifugation. The stability of PON1 activity in the patient serum was almost the same as in the normal control sera throughout incubation at 14 degrees C for 7 days. However, when the sera were incubated at 37 degrees C for 24 h, its activity declined more than those in the normal controls (19% versus 4% reduction of the initial values). Our results demonstrated that PON1 protein possesses a preferential association with HDL even in the absence of apoA-I, although apoA-I is a crucial factor for the maximal activity and stabilization of PON1.
authors.affiliation: Department of Metabolic Diseases, University of Tokyo, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Noto
authors.forename: Y
authors.initials: Y
authors.lastname: Hashimoto
authors.forename: H
authors.initials: H
authors.lastname: Satoh
authors.forename: M
authors.initials: M
authors.lastname: Hara
authors.forename: N
authors.initials: N
authors.lastname: Iso-o
authors.forename: M
authors.initials: M
authors.lastname: Togo
authors.forename: S
authors.initials: S
authors.lastname: Kimura
authors.forename: K
authors.initials: K
authors.lastname: Tsukamoto
mesh_terms: D000368:Aged; D016632:Apolipoprotein A-I / Q000172:deficiency* / Q000378:metabolism*; D001053:Apolipoproteins / Q000097:blood; D043303:Aryldialkylphosphatase; D015153:Blotting, Western; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D002850:Chromatography, Gel; D002853:Chromatography, Liquid; D004950:Esterases / Q000097:blood* / Q000235:genetics* / Q000378:metabolism*; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL / Q000378:metabolism*; D011110:Polymorphism, Genetic; D011485:Protein Binding; D013696:Temperature; D013997:Time Factors; D014461:Ultracentrifugation
chemical_list: D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D008075:Lipoproteins, HDL; D002784:Cholesterol; D004950:Esterases; D043303:Aryldialkylphosphatase; C468406:PON1 protein, human